Abstract:Background and Objective: Severe neonatal anaemia can impair cerebral oxygen supply. Data on long-term outcomes following severe neonatal anaemia are scarce. Methods: Clinical data and neurodevelopmental outcome of 49 (near) term infants with haemoglobin concentration after birth <6.0 mmol/l were retrospectively collected and analysed. In a subgroup of 28 patients, amplitude-integrated EEG was available and in 25 infants cerebral MRI was obtained. Infants were followed up at 14-35 months of age and assessed wi… Show more
“…Moreover, they did not report their rate of mortality, which may also have accounted for differences between their and our results. In line with our results, Zonnenberg et al [13] showed normal NDOs in all surviving infants born with anemia and they suggested that neonatal anemia itself did not significantly affect the long-term outcome. Neurodevelopmental tests, however, were not routinely performed in their study.…”
Section: Discussionsupporting
confidence: 93%
“…Third, the cut-off value of 7 mmol/L that we chose to define perinatal anemia may also account for these positive results, because it was slightly higher compared with other studies [13,14]. The anemic group may comprise some infants who did not suffer from severe perinatal anemia.…”
Section: Discussionmentioning
confidence: 95%
“…In a study performed between 2000 and 2011, 18 (37%) severely anemic patients died within 72 h after birth [13]. Muraskas et al [14] also reported higher mortality rates in infants with perinatal anemia leading to birth asphyxia.…”
Background: Perinatal anemia may cause perinatal asphyxia. Its pathophysiology and neurodevelopmental effects are theoretically different from other causes of perinatal asphyxia. Objective: The study aimed to determine whether perinatal anemia results in different short-term and long-term outcomes than other causes of perinatal asphyxia treated with therapeutic hypothermia. Methods: We retrospectively included infants with moderate to severe hypoxic-ischemic encephalopathy, born between May 2009 and October 2015. During follow-up, we assessed cognitive and motor development at 2–3 years of age, using the Bayley Scales of Infant and Toddler Development, third edition (BSID-III). Neurodevelopmental outcome (NDO) was classified as abnormal in case of cerebral palsy with Gross Motor Function Classification System ≥III and/or a BSID-III composite score < 85. Outcomes of infants with perinatal anemia (initial hemoglobin < 7 mmol/L) were compared to infants born with perinatal asphyxia due to other causes. Results: In total, 111 infants were included of whom 30 infants (27%) died during the neonatal period. Infants with anemia (n = 23) had a higher mortality risk, OR 3.33, 95% CI 1.27–8.72, p = 0.01. None of the surviving infants with anemia (n = 12) had an abnormal NDO, in contrast to 26/69 (38%) with neurodevelopmental impairments, particularly motor problems, in the non-anemic group, p < 0.01. Conclusions: Perinatal anemia causing moderate to severe perinatal asphyxia is associated with a higher risk for neonatal mortality. All survivors with perinatal anemia, however, showed a normal NDO in contrast to children who were born asphyxiated due to other causes. The underlying pathophysiological mechanism for the favorable NDO in the perinatal anemia group needs further elucidation.
“…Moreover, they did not report their rate of mortality, which may also have accounted for differences between their and our results. In line with our results, Zonnenberg et al [13] showed normal NDOs in all surviving infants born with anemia and they suggested that neonatal anemia itself did not significantly affect the long-term outcome. Neurodevelopmental tests, however, were not routinely performed in their study.…”
Section: Discussionsupporting
confidence: 93%
“…Third, the cut-off value of 7 mmol/L that we chose to define perinatal anemia may also account for these positive results, because it was slightly higher compared with other studies [13,14]. The anemic group may comprise some infants who did not suffer from severe perinatal anemia.…”
Section: Discussionmentioning
confidence: 95%
“…In a study performed between 2000 and 2011, 18 (37%) severely anemic patients died within 72 h after birth [13]. Muraskas et al [14] also reported higher mortality rates in infants with perinatal anemia leading to birth asphyxia.…”
Background: Perinatal anemia may cause perinatal asphyxia. Its pathophysiology and neurodevelopmental effects are theoretically different from other causes of perinatal asphyxia. Objective: The study aimed to determine whether perinatal anemia results in different short-term and long-term outcomes than other causes of perinatal asphyxia treated with therapeutic hypothermia. Methods: We retrospectively included infants with moderate to severe hypoxic-ischemic encephalopathy, born between May 2009 and October 2015. During follow-up, we assessed cognitive and motor development at 2–3 years of age, using the Bayley Scales of Infant and Toddler Development, third edition (BSID-III). Neurodevelopmental outcome (NDO) was classified as abnormal in case of cerebral palsy with Gross Motor Function Classification System ≥III and/or a BSID-III composite score < 85. Outcomes of infants with perinatal anemia (initial hemoglobin < 7 mmol/L) were compared to infants born with perinatal asphyxia due to other causes. Results: In total, 111 infants were included of whom 30 infants (27%) died during the neonatal period. Infants with anemia (n = 23) had a higher mortality risk, OR 3.33, 95% CI 1.27–8.72, p = 0.01. None of the surviving infants with anemia (n = 12) had an abnormal NDO, in contrast to 26/69 (38%) with neurodevelopmental impairments, particularly motor problems, in the non-anemic group, p < 0.01. Conclusions: Perinatal anemia causing moderate to severe perinatal asphyxia is associated with a higher risk for neonatal mortality. All survivors with perinatal anemia, however, showed a normal NDO in contrast to children who were born asphyxiated due to other causes. The underlying pathophysiological mechanism for the favorable NDO in the perinatal anemia group needs further elucidation.
“…Perinatal anemia causing HIE has been associated with higher neonatal mortality. 60,61 However, survivors of severe perinatal anemia have been also described to have reassuring neurodevelopmental outcomes at 2 to 3 years of age. 60,61 In summary, there are only limited data available on the prognostic value of biochemical parameters on neurodevelopmental outcomes.…”
Hypoxic-ischemic encephalopathy (HIE) is a manifestation of perinatal asphyxial insult that continues to evolve over days to weeks following the initial injury. Therapeutic hypothermia has demonstrated that a proportion of this secondary brain injury may indeed be preventable. However, therapeutic hypothermia has also altered the prognostic utility of many bedside tools that are commonly used as predictors of long-term neurodevelopmental outcome in HIE. Clinicians are often confronted with uncertainty when assessing the prognosis of infants with HIE. Improved understanding of the implications and limitations of individual investigations may inform clinical decisions and allow for timely intervention. This review summarizes the predictive value of currently available prognostic markers in HIE infants in the therapeutic hypothermia era, including clinical, biochemical, neurophysiological, physiological, and neuroimaging predictors.
“…Prenatal iron deficiency affects the normal development of brain structures, neurotransmitter systems and myelination [12]; therefore, anaemia and iron deficiency are largely demonstrated to be associated with impaired psychomotor development, impaired performance in language tests, and in motor and coordination skills [13][14][15]. DCC performed in the first minutes after birth, allows newborn, either to anaemic and nonanaemic mothers, to receive a substantial blood transfusion from placenta and increase blood volume of an average 32%, leading to obtain higher birthweight and haemoglobin concentration [8].…”
Objective: To investigate the effect of a 2 minutes-delayed cord clamp (DCC) versus early cord clamp (ECC) on neonate haemoglobin concentration 24 hours and 1 month after birth, and assess the safety of DCC concerning the risk of HIV infection. Design: Sixty-four mother-infant peers were enrolled. All mothers were on stable ARV therapy. Viral load, CD4 þ count and blood haemoglobin (Hb) concentrations 24 hours before delivery were collected from all mothers and their infants. Methods: All patients were enrolled at the Department of Paediatrics, AO FBF Sacco Hospital in Milan, and were followed until 18 months after birth. Women with haematological diseases and obstetrical complications were excluded. All of 64 mother and infants couples (32 ECC group and 32 DCC group) completed the study. ECC and DCC are defined as application of umbilical clamp within 30 seconds and 120 seconds after birth, respectively. Results: Mean birth weight was significantly higher in the DCC compared with ECC group. Mean Hb levels at birth were significantly higher in DCC than in ECC group (p ¼ .05): this difference persisted at 1 month of life. All newborns showed negative viral load. Conclusions: DCC 2 minutes after birth is proven to be a safe procedure, particularly beneficial in newborns from HIV mothers. The risk of anemia is significantly decreased at 24 hours after birth and persists at age of 1 month without any increased risk of neonatal jaundice or polycitemia.
ARTICLE HISTORY
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.